Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.4 (
RNase H
)
2,751
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Studies were performed in the rat liver to examine whether or not
insulin
as well as glucagon causes the induction of mitochondrial serine:pyruvate aminotransferase (SPTm) [EC 2.6.1.51] and if so, whether the mechanisms of induction are similar or different for the two hormones. Not only glucagon but also
insulin
induced SPTm. Cell-free translation assaying and RNA blot analysis showed that both hormones cause an increase in the hepatic level of mRNA for the precursor of SPTm. Their effects were virtually additive, and the time course of the increase in the mRNA level differed between the hormones. The maximal increase induced by glucagon was observed 3.5 h after the hormone injection while that by
insulin
was found after 6 h. The increase in the mRNA due to
insulin
was completely inhibited by the co-administration of cycloheximide, while that due to glucagon was not. The finding suggests that a newly synthesized,
insulin
-dependent protein(s) is involved in the regulation of the mRNA level by
insulin
. On the other hand, hydrocortisone treatment selectively suppressed the increase in the mRNA due to glucagon. These data indicate that the synthesis of the mRNA for SPTm is regulated by glucagon and
insulin
through different mechanisms. The size of the hormone-induced mRNA for SPTm gradually decreased with time, but the cell-free translation products did not exhibit size alteration.
RNase H
digestion to remove the poly(A) tail of the mRNA indicated that shortening of the poly(A) sequence might be responsible for the time-dependent size alteration of the mRNA.
...
PMID:Induction of mitochondrial serine:pyruvate aminotransferase of rat liver by glucagon and insulin through different mechanisms. 256 60
Proinsulin mRNA was analyzed by RNA blot hybridization from four
insulin
-expressing tissues of the rat, including adult and fetal pancreas, yolk sac, and an insulinoma cell line (RIN 5F). The proinsulin mRNA transcripts from the insulinoma cell line and fetal pancreatic tissue were estimated to be, respectively, 100 and 50 bases larger than the transcript from adult pancreas. Yolk sac proinsulin mRNA comigrated with the fetal transcript. While glucose is an important regulator of proinsulin mRNA in the adult, there is a marked increase in the concentrations of proinsulin mRNA and
insulin
in the developing rat, although plasma glucose levels are quite low. Expression of proinsulin mRNA independent of glucose levels is also found in insulinoma tissue. In addition, there is a second TATA sequence upstream of the putative start site in rat
insulin
II gene, and the transcription initiation site(s) has not been mapped in all of these tissues. These observations suggested that alternative transcription initiation sites may place the genes under different promoter control during development. To map the 5' end of the gene, primer extension was performed using a synthetic oligonucleotide primer complementary to the first 20 bases of the coding portion of the rat
insulin
I gene. The extended products of the proinsulin mRNAs from adult insulinoma cell line and fetal pancreas were identical and consistent in size with those predicted if transcription occurs at the putative start site. The 3' ends of the proinsulin mRNA transcripts were evaluated by
ribonuclease H
digestion, and it was shown that the noted size differences could be accounted for by different lengths of 3'-polyadenylation. Northern blot analysis of proinsulin mRNA from animals treated under conditions where mRNA varied from low to high levels failed to show any modulation of polyadenylation. The role of polyadenylation of proinsulin mRNA in the physiological regulation of
insulin
biosynthesis, if any, is currently unknown.
...
PMID:Identical transcription initiation sites for proinsulin messenger ribonucleic acid in three insulin-expressing tissues. 300 26
Obese
insulin
resistant animals and humans have shown reduced GLUT4 gene expression. Yet, in skeletal muscle, discrepancy between mRNA and protein regulation has been frequently observed, suggesting a post-transcriptional modulation. We investigated the GLUT4 expression in adipose tissue and muscle of obese 12-month-old (12-mo) rats, comparing with lean 2-month-old (2-mo) animals. Obesity was accompanied by
insulin
resistance, and 65% reduction (P<0.01) in GLUT4 mRNA and protein in adipose tissue. However, in muscle, despite increased (P<0.05) mRNA content, GLUT4 protein was unchanged.
RNase H
and poly(A) test assays showed a reduction (P<0.01) of approximately 80 adenines in the GLUT4 mRNA poly(A) tail of muscle from 12-mo rats, recognizing that the poly(A) tail length correlates with translation efficiency. Concluding, age related obesity of 12-mo rats involves suppression of GLUT4 expression in adipose tissue; however, in muscle, GLUT4 mRNA content increases, but with a shorter poly(A) tail, thus unchanging the protein content.
...
PMID:Age related obesity-induced shortening of GLUT4 mRNA poly(A) tail length in rat gastrocnemius skeletal muscle. 1770 77